[J01EC01, sulfamethoxazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Sulfamethoxazole.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Ivermectin.]
[G03BA03, testosterone, The excretion of Testosterone can be decreased when combined with Ivermectin.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Triamcinolone.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Triazolam.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Ivermectin.]
[J01FA08, troleandomycin, The metabolism of Ivermectin can be decreased when combined with Troleandomycin.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[A10BH05, linagliptin, The metabolism of Ivermectin can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Ivermectin can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Ivermectin can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, Rilpivirine may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[C08DA01, verapamil, The metabolism of Ivermectin can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Ivermectin can be decreased when combined with Viloxazine.]
[L01CA02, vincristine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Ivermectin.]
[B01AA03, warfarin, Ivermectin may increase the anticoagulant activities of Warfarin.]
[S01AA13, fusidic acid, The metabolism of Ivermectin can be decreased when combined with Fusidic acid.]
[J05AF01, zidovudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ivermectin.]
[J05AE02, indinavir, The metabolism of Ivermectin can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, Vemurafenib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Ivermectin.]
[L01ED01, crizotinib, The metabolism of Ivermectin can be decreased when combined with Crizotinib.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Ibandronate.]
[N05AE04, ziprasidone, The metabolism of Ivermectin can be decreased when combined with Ziprasidone.]
[J02AC03, voriconazole, The metabolism of Ivermectin can be decreased when combined with Voriconazole.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01EK01, axitinib, The excretion of Axitinib can be decreased when combined with Ivermectin.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Ivermectin.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ivermectin.]
[V03AX03, cobicistat, The metabolism of Ivermectin can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Ivermectin can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Ivermectin can be decreased when it is combined with Enzalutamide.]
[L04AA31, teriflunomide, Teriflunomide may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Ivermectin can be decreased when combined with Nelfinavir.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Ivermectin.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Ivermectin.]
[L01EA05, ponatinib, Ponatinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J02AX04, caspofungin, The excretion of Caspofungin can be decreased when combined with Ivermectin.]
[L01EC02, dabrafenib, The serum concentration of Ivermectin can be decreased when it is combined with Dabrafenib.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Ivermectin.]
[J05AP05, simeprevir, The metabolism of Ivermectin can be decreased when combined with Simeprevir.]
[A16AA07, metreleptin, The metabolism of Ivermectin can be increased when combined with Metreleptin.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Ivermectin.]
[C10AB02, bezafibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Bezafibrate.]
[B01AA07, acenocoumarol, Ivermectin may increase the anticoagulant activities of Acenocoumarol.]
[N07XX08, tafamidis, The serum concentration of Ivermectin can be increased when it is combined with Tafamidis.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[B01AA01, dicumarol, Ivermectin may increase the anticoagulant activities of Dicoumarol.]
[L01EF01, palbociclib, Palbociclib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[B01AA11, tioclomarol, Ivermectin may increase the anticoagulant activities of Tioclomarol.]
[J05AP06, asunaprevir, The excretion of Asunaprevir can be decreased when combined with Ivermectin.]
[A07DA06, eluxadoline, The serum concentration of Eluxadoline can be increased when it is combined with Ivermectin.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Acipimox.]
[A02BC03, lansoprazole, Lansoprazole may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Trabectedin.]
[J02AC05, isavuconazole, The metabolism of Ivermectin can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, Osimertinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The excretion of Tenofovir alafenamide can be decreased when combined with Ivermectin.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[B01AC27, selexipag, The excretion of Selexipag can be decreased when combined with Ivermectin.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01XX52, venetoclax, The metabolism of Ivermectin can be decreased when combined with Venetoclax.]
[C03CA02, bumetanide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Bumetanide.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01XK03, rucaparib, Rucaparib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[S01AA26, azithromycin, The serum concentration of Ivermectin can be increased when it is combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Ivermectin can be decreased when combined with Ribociclib.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Ivermectin can be decreased when combined with Tipranavir.]
[L04AB02, infliximab, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ivermectin.]
[L01EX10, midostaurin, The metabolism of Ivermectin can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, Brigatinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01XX59, enasidenib, Enasidenib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Ivermectin can be decreased when combined with Efavirenz.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Captopril.]
[L02BB05, apalutamide, The metabolism of Ivermectin can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Ivermectin can be increased when combined with Carbamazepine.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Ivermectin.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[B02BX08, avatrombopag, Avatrombopag may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[H01CC03, elagolix, The excretion of Elagolix can be decreased when combined with Ivermectin.]
[L01XX62, ivosidenib, The metabolism of Ivermectin can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Ivermectin can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, Dacomitinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[R03BB08, revefenacin, Ivermectin may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Ciprofibrate.]
[J01FA09, clarithromycin, The metabolism of Ivermectin can be decreased when combined with Clarithromycin.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Ubidecarenone.]
[L02BB06, darolutamide, The serum concentration of Ivermectin can be increased when it is combined with Darolutamide.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[N07XX11, pitolisant, The serum concentration of Ivermectin can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Ivermectin.]
[N02CC08, lasmiditan, The serum concentration of Ivermectin can be increased when it is combined with Lasmiditan.]
[N03AX25, cenobamate, The serum concentration of Ivermectin can be decreased when it is combined with Cenobamate.]
[C10AX15, bempedoic acid, The excretion of Bempedoic acid can be decreased when combined with Ivermectin.]
[J05AE05, amprenavir, The metabolism of Ivermectin can be decreased when combined with Amprenavir.]
[C01BD07, dronedarone, The metabolism of Ivermectin can be decreased when combined with Dronedarone.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Ivermectin.]
[L01EX17, capmatinib, The serum concentration of Ivermectin can be increased when it is combined with Capmatinib.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01FX15, belantamab mafodotin, The excretion of Belantamab mafodotin can be decreased when combined with Ivermectin.]
[L04AC19, satralizumab, The serum concentration of Ivermectin can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Chloroquine.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[V04CK02, cholecystokinin, The excretion of Cholecystokinin can be decreased when combined with Ivermectin.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Etofibrate.]
[B06AC06, berotralstat, The metabolism of Ivermectin can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Ivermectin can be decreased when combined with Lonafarnib.]
[P03AX07, abametapir, The serum concentration of Ivermectin can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, Tepotinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[A02BA01, cimetidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cimetidine is combined with Ivermectin.]
[L01XX73, sotorasib, The serum concentration of Ivermectin can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Ivermectin can be decreased when combined with Ciprofloxacin.]
[L04AA48, belumosudil, Belumosudil may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Ivermectin.]
[N06AX25, St. John's wort extract, The metabolism of Ivermectin can be increased when combined with St. John's Wort.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[C10AB01, clofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Clofibrate.]
[L01EJ03, pacritinib, The serum concentration of Ivermectin can be increased when it is combined with Pacritinib.]
[J05AB17, brincidofovir, The serum concentration of Brincidofovir can be increased when it is combined with Ivermectin.]
[C01EB24, mavacamten, The serum concentration of Ivermectin can be decreased when it is combined with Mavacamten.]
[J02AC06, oteseconazole, The serum concentration of Ivermectin can be increased when it is combined with Oteseconazole.]
[N05AH02, clozapine, The metabolism of Ivermectin can be decreased when combined with Clozapine.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Ivermectin can be increased when combined with Somatrogon.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Colchicine.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Leflunomide.]
[J01FA15, telithromycin, The metabolism of Ivermectin can be decreased when combined with Telithromycin.]
[J02AC02, itraconazole, The metabolism of Ivermectin can be decreased when combined with Itraconazole.]
[L01EA01, imatinib, Imatinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J02AC04, posaconazole, The metabolism of Ivermectin can be decreased when combined with Posaconazole.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Nafarelin.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Mebeverine.]
[S01XA18, cyclosporine, The metabolism of Ivermectin can be decreased when combined with Cyclosporine.]
[C10AA07, rosuvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Rosuvastatin.]
[C03XA02, conivaptan, The metabolism of Ivermectin can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Cytarabine.]
[G03XA01, danazol, The metabolism of Ivermectin can be decreased when combined with Danazol.]
[N06AX06, nefazodone, The metabolism of Ivermectin can be decreased when combined with Nefazodone.]
[S03BA01, dexamethasone, The metabolism of Ivermectin can be increased when combined with Dexamethasone.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01EB02, erlotinib, Erlotinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[C08CA03, isradipine, The metabolism of Ivermectin can be decreased when combined with Isradipine.]
[C01AA05, digoxin, The excretion of Digoxin can be decreased when combined with Ivermectin.]
[C10AX09, ezetimibe, The excretion of Ezetimibe can be decreased when combined with Ivermectin.]
[J05AE08, atazanavir, The metabolism of Ivermectin can be decreased when combined with Atazanavir.]
[C08DB01, diltiazem, The metabolism of Ivermectin can be decreased when combined with Diltiazem.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Ivermectin.]
[S02AA12, rifamycin SV, The metabolism of Ivermectin can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Ivermectin can be increased when combined with Rifapentine.]
[L01EX01, sunitinib, Sunitinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[A04AD12, aprepitant, The metabolism of Ivermectin can be decreased when combined with Aprepitant.]
[C02KX02, ambrisentan, The excretion of Ambrisentan can be decreased when combined with Ivermectin.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Salmeterol.]
[C10AA01, simvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Simvastatin.]
[N02CC01, sumatriptan, The excretion of Sumatriptan can be decreased when combined with Ivermectin.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Terbinafine.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Tianeptine.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Ivermectin.]
[C03CA04, torsemide, The excretion of Torasemide can be decreased when combined with Ivermectin.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Ivermectin which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The metabolism of Ivermectin can be decreased when combined with Barnidipine.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Iloprost.]
[N02CA02, ergotamine, The metabolism of Ivermectin can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Ivermectin can be decreased when combined with Erythromycin.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Ivermectin.]
[C10AA04, fluvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Fluvastatin.]
[L04AD02, tacrolimus, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Tacrolimus.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Ivermectin.]
[R06AX12, terfenadine, The metabolism of Ivermectin can be decreased when combined with Terfenadine.]
[N06AB08, fluvoxamine, The metabolism of Ivermectin can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ivermectin.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Ivermectin.]
[J02AC01, fluconazole, The metabolism of Ivermectin can be decreased when combined with Fluconazole.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Ethanol.]
[J05AE10, darunavir, The metabolism of Ivermectin can be decreased when combined with Darunavir.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Alendronic acid.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Ganciclovir.]
[C10AB04, gemfibrozil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Gemfibrozil.]
[L01EA02, dasatinib, Dasatinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[B01AA12, fluindione, Ivermectin may increase the anticoagulant activities of Fluindione.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Ivermectin.]
[A07EC02, mesalamine, The excretion of Mesalazine can be decreased when combined with Ivermectin.]
[C08CA10, nilvadipine, The metabolism of Ivermectin can be decreased when combined with Nilvadipine.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Risedronic acid.]
[L01CD01, paclitaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Paclitaxel.]
[N06AX17, milnacipran, The metabolism of Ivermectin can be decreased when combined with Milnacipran.]
[C10AA06, cerivastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cerivastatin is combined with Ivermectin.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Ipecac.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Stavudine.]
[J04AC01, isoniazid, The metabolism of Ivermectin can be decreased when combined with Isoniazid.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Isotretinoin.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ivermectin.]
[J02AB02, ketoconazole, The metabolism of Ivermectin can be decreased when combined with Ketoconazole.]
[P02CE01, levamisole, The bioavailability of Ivermectin can be increased when combined with Levamisole.]
[C10AA02, lovastatin, The metabolism of Ivermectin can be decreased when combined with Lovastatin.]
[L01EA03, nilotinib, The metabolism of Ivermectin can be decreased when combined with Nilotinib.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Ivermectin.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Lamivudine.]
[H03BB02, methimazole, The metabolism of Ivermectin can be decreased when combined with Methimazole.]
[L04AX03, methotrexate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methotrexate is combined with Ivermectin.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Methyldopa.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Metoclopramide.]
[S02AA13, miconazole, The metabolism of Ivermectin can be decreased when combined with Miconazole.]
[C09CA03, valsartan, The excretion of Valsartan can be decreased when combined with Ivermectin.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Minocycline.]
[L01XX23, mitotane, The metabolism of Ivermectin can be increased when combined with Mitotane.]
[C01BD01, amiodarone, The metabolism of Ivermectin can be decreased when combined with Amiodarone.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Raltegravir.]
[G03XC01, raloxifene, The excretion of Raloxifene can be decreased when combined with Ivermectin.]
[N03AB05, fosphenytoin, The metabolism of Ivermectin can be increased when combined with Fosphenytoin.]
[V03AB15, naloxone, The metabolism of Ivermectin can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Naltrexone.]
[L01CD02, docetaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Docetaxel.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Letrozole.]
[A10BX02, repaglinide, The excretion of Repaglinide can be decreased when combined with Ivermectin.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Ivermectin can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Ivermectin can be decreased when combined with Febuxostat.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Ivermectin can be decreased when combined with Nicardipine.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Norfloxacin.]
[C02KX01, bosentan, The excretion of Bosentan can be decreased when combined with Ivermectin.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Ofloxacin.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[C01AC01, ouabain, The excretion of Ouabain can be decreased when combined with Ivermectin.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Penicillamine.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Ivermectin.]
[N05CA01, pentobarbital, The metabolism of Ivermectin can be increased when combined with Pentobarbital.]
[B01AA02, phenindione, Ivermectin may increase the anticoagulant activities of Phenindione.]
[N03AA02, phenobarbital, The metabolism of Ivermectin can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, Ivermectin may increase the anticoagulant activities of Phenprocoumon.]
[N03AB02, phenytoin, The metabolism of Ivermectin can be increased when combined with Phenytoin.]
[C10AA05, atorvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Atorvastatin.]
[J05AE01, saquinavir, The metabolism of Ivermectin can be decreased when combined with Saquinavir.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Eprosartan.]
[J05AG02, delavirdine, The metabolism of Ivermectin can be decreased when combined with Delavirdine.]
[J05AE03, ritonavir, The serum concentration of Ivermectin can be increased when it is combined with Ritonavir.]
[C10AA08, pitavastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Pitavastatin.]
[P01BA03, primaquine, The metabolism of Ivermectin can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Ivermectin can be increased when combined with Primidone.]
[C01BA02, procainamide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Procainamide.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Fenofibrate.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Ivermectin.]
[L01XH02, romidepsin, The excretion of Romidepsin can be decreased when combined with Ivermectin.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Propofol.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Ivermectin.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Ivermectin.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Ranitidine.]
[J04AB02, rifampin, The metabolism of Ivermectin can be increased when combined with Rifampicin.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[V04CC03, sincalide, The excretion of Sincalide can be decreased when combined with Ivermectin.]
[L01CD04, cabazitaxel, Cabazitaxel may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[H02CA04, levoketoconazole, The metabolism of Ivermectin can be decreased when combined with Levoketoconazole.]
